Qi-shun Sun
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Intestinal Ischemia/Reperfusion Injury: Mechanisms, Diagnosis, and Therapeutic Advances.
Journal: International journal of biological sciences
Published: December 16, 2025
Chac1 deficiency confers sepsis resistance by enriching gut microbiota-derived indole-3-carboxylic acid to drive macrophage metabolic shifts.
Journal: Journal of advanced research
Published: December 11, 2025
Organoids transplantation attenuates intestinal ischemia/reperfusion injury in mice through L-Malic acid-mediated M2 macrophage polarization.
Journal: Nature communications
Published: February 01, 2023
Gut microbiota dysbiosis is associated with sepsis-induced cardiomyopathy in patients: A case-control study.
Journal: Journal of medical virology
Published: September 28, 2022
Gut microbe-derived milnacipran enhances tolerance to gut ischemia/reperfusion injury.
Journal: Cell reports. Medicine
Published: September 04, 2022
The role of intestinal microbiota and its metabolites in intestinal and extraintestinal organ injury induced by intestinal ischemia reperfusion injury.
Journal: International journal of biological sciences
Published: January 27, 2022
Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41.
Journal: International journal of biological sciences
Published: October 04, 2021
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells via IL-33/ST2 Signaling.
Journal: Frontiers in immunology
Published: May 04, 2021
The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis.
Journal: Gut microbes
Published: March 29, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026